Predictors of residual mitral regurgitation after left ventricular assist device implantation.


Journal

The International journal of artificial organs
ISSN: 1724-6040
Titre abrégé: Int J Artif Organs
Pays: United States
ID NLM: 7802649

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 18 7 2020
medline: 29 5 2021
entrez: 18 7 2020
Statut: ppublish

Résumé

Patients with advanced heart failure often have functional mitral regurgitation. Left ventricular assist device implantation improves functional mitral regurgitation through left ventricular unloading. However, residual mitral regurgitation after left ventricular assist device implantation leads to adverse outcomes, and whether patients need concomitant mitral valve surgery is not fully elucidated. Therefore, this study aimed to elucidate the predictors of residual mitral regurgitation and to describe the temporal changes in residual mitral regurgitation. We retrospectively enrolled 15 patients with implantable continuous-flow left ventricular assist device, who had significant mitral regurgitation on echocardiography before left ventricular assist device implantation. Three patients had residual mitral regurgitation (mitral regurgitation color jet area/left atrial area >0.2) 1 month after left ventricular assist device implantation. We investigated factors associated with residual mitral regurgitation and compared patients with or without residual mitral regurgitation. On univariate analysis, mitral valve tethering area and mitral regurgitation vena contracta before left ventricular assist device implantation were significantly associated with residual mitral regurgitation (odds ratio, 1.03;

Identifiants

pubmed: 32677853
doi: 10.1177/0391398820942526
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

101-109

Auteurs

Yuki Kimura (Y)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Takahiro Okumura (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shingo Kazama (S)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naoki Shibata (N)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hideo Oishi (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Yoshihito Arao (Y)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Tasuku Kuwayama (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hiroo Kato (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Shogo Yamaguchi (S)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Hiroaki Hiraiwa (H)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toru Kondo (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Ryota Morimoto (R)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Masato Mutsuga (M)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Kazuro Fujimoto (K)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Akihiko Usui (A)

Department of Cardiac Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Toyoaki Murohara (T)

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH